Chongqing Lummy Pharmaceutical Co Ltd
SZSE:300006

Watchlist Manager
Chongqing Lummy Pharmaceutical Co Ltd Logo
Chongqing Lummy Pharmaceutical Co Ltd
SZSE:300006
Watchlist
Price: 5.23 CNY -1.13% Market Closed
Market Cap: ¥5.5B

Wall Street
Price Targets

Price Targets Summary
Chongqing Lummy Pharmaceutical Co Ltd

There are no price targets for Chongqing Lummy Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Chongqing Lummy Pharmaceutical Co Ltd Competitors:
Price Targets
FCBC
First Community Bankshares Inc
15% Upside
SMG
Scotts Miracle-Gro Co
18% Upside

Revenue
Forecast

3% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
3% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Chongqing Lummy Pharmaceutical Co Ltd's revenue is 3%. The projected CAGR for the next 3 years is 11%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-45%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-45%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Chongqing Lummy Pharmaceutical Co Ltd's stock price target?
Not Available

Chongqing Lummy Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Chongqing Lummy Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Chongqing Lummy Pharmaceutical Co Ltd's revenue is 3%. The projected CAGR for the next 3 years is 11%.

Back to Top